First-trimester screening for Down's syndrome in in vitro fertilization pregnancies

By Niemimaa M.   Heinonen S.   Seppala M.   Hippelainen M.   Martikainen H.   Ryynanen M.  

Fertility and Sterility, Vol. 76, Iss. 6, 2001-12 ,pp. : 1282-1283

Elsevier

Access to resources Recommend Favorite

Effect of a prostaglandin E 1 analogue (gemeprost) on uterine and luteal circulation in normal first trimester pregnancies. A Doppler velocimetry study

By Valentin L.   Sladkevicius P.   Laurini R.   Soderberg H.   Olofsson P.   Marsal K.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 59, Iss. 1, 1995-03 ,pp. : 25-34

Elsevier

Access to resources Recommend Favorite

Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial

By Carbonell J. L.   Velazco A.   Rodriguez Y.   Tanda R.   Sánchez C.   Barambio S.   Valera L.   Chami S.   Valero F.   Aragón S.   Marí J.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 3, 2001-09 ,pp. : 134-140

Informa Healthcare

Access to resources Recommend Favorite

The effect of oral versus vaginal misoprostol on cervical dilatation in first-trimester abortion: a double-blind, randomized study

By Inal M. M.   Ertopçu K.   Arici A.   Özelmas I.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 4, 2003-12 ,pp. : 197-202

Informa Healthcare

Access to resources Recommend Favorite

First-trimester pregnancy termination with 800 μg of vaginal misoprostol every 12 h

By Salakos N.   Kountouris A.   Botsis D.   Rizos D.   Gregoriou O.   Detsis G.   Creatsas G.  

The European Journal of Contraception and Reproductive Health Care, Vol. 10, Iss. 4, 2005-12 ,pp. : 249-254

Informa Healthcare

Access to resources Recommend Favorite